Contents Menu

Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy

OncoImmunology Volume 3 Issue 2 Page e27680-
published_at 2014
Title
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
Creators Song Chang
Creators Sadashivaiah Kavitha
Creators Furusawa Aki
Creators Davila Eduardo
Creators Tamada Koji
Creators Banerjee Arnob
Languages eng
Resource Type journal article
Publishers Landes Bioscience
Date Issued 2014
File Version Not Applicable (or Unknown)
Access Rights metadata only access
Relations
[ISSN]2162-402X
[PMID]info:pmid/24790793
info:doi/10.4161/onci.27680
[isVersionOf] [URI]https://www.landesbioscience.com/journals/oncoimmunology/
Schools 大学院医学系研究科(医学)